Liquidambar chinensis
Liquidambar chinensis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Liquidambar chinensis is a botanical species recognized for its significant pharmacological potential in traditional and modern medicine. Recent studies have highlighted its diverse biological activities, most notably its potent antitumor properties. When processed as a petroleum ether extract, the plant reveals concentrated bioactive compounds capable of addressing complex health issues. These extracts are particularly noted for their therapeutic efficacy in treating conditions such as paralysis and rheumatism. Consequently, this plant remains a subject of intense interest for researchers exploring natural alternatives for neurological and inflammatory management.
- Synonyms
- Altingia Chinensis · Altingia Chinensis F. Pubescens
- Common names
- Not available
- Family
- Altingiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Liquidambar chinensis is a fascinating species known by many diverse regional names across different cultures. In certain areas, it is affectionately referred to by the common name Gai Bôm. It is also frequently called Mountain Litchi, a name that highlights its unique characteristics. Depending on the linguistic context, you may encounter it as To Hap Trung Hoa or the Chinese designation 中華蕈樹. Finally, the plant is widely recognized by the name 山荔枝, showcasing the rich variety of nomenclature used to describe it.
Sources: Catalogue of Life (COL)
Synonyms
Liquidambar chinensis is a botanical species that is frequently identified by its various taxonomic synonyms. In many scientific records, the plant is also referred to by the name Altingia chinensis. Furthermore, certain specialized varieties within this group are classified as Altingia chinensis f. pubescens. These overlapping designations reflect the complex historical classification of the species. Understanding these synonymous relationships is essential for accurate identification in botanical studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Liquidambar chinensis belongs to the vast kingdom Plantae, marking its place among the diverse world of plants. Within this kingdom, it is classified under the class Equisetopsida. The species is further organized into the order Saxifragales, showcasing its unique evolutionary lineage. It finds its specific home within the family Altingiaceae, which defines its botanical characteristics. Finally, this plant is a prominent member of the genus Liquidambar, rounding out its formal scientific identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Saxifragales |
| Family | Altingiaceae |
| Genus | Liquidambar |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Liquidambar chinensis exhibits a broad geographical presence across several diverse ecological zones. Within the Asia-Temperate region, the species is widely distributed throughout China, specifically spanning the South-Central and Southeast territories. Its range also extends southward to include the tropical island of Hainan. Moving into the Asia-Tropical zone, the plant can be found stretching through Indo-China. This extensive distribution highlights the species' ability to thrive in both temperate and tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Liquidambar chinensis grows in a stately tree form that commands attention in any landscape. As a self-supporting species, it maintains a sturdy and independent structure as it matures.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Liquidambar chinensis, specifically through its petroleum ether extract, has demonstrated significant antitumor activity against non-small-cell lung cancer (NSCLC). Research indicates that this extract works by inducing apoptosis and decreasing the viability of cancer cells in both in vitro and in vivo models. Furthermore, the extract effectively suppresses cell migration and invasion by attenuating the epithelial-mesenchymal transition (EMT) process. At a molecular level, the antitumor mechanism involves the direct inhibition of the PI3K/Akt signaling pathway. These findings suggest that the plant holds substantial potential as a foundation for developing novel therapeutic drugs to combat lung cancer.
Compounds
Conditions
Liquidambar chinensis, also referred to as Altingia chinensis, serves as a traditional folk remedy used to alleviate rheumatism, paralysis, and punch injury. Beyond these traditional uses, its petroleum ether extract has demonstrated significant potential in treating non-small-cell lung cancer (NSCLC). The extract suppresses NSCLC by inducing apoptosis and attenuating epithelial-mesenchymal transition (EMT) in cancer cells. Additionally, it works by downregulating the PI3K/Akt pathway to inhibit tumor growth. These diverse therapeutic properties highlight the plant's multifaceted medicinal utility.
Preparations
Liquidambar chinensis is prepared as a petroleum ether extract to explore its potential therapeutic properties. This specific extract, referred to as APE, has been investigated for its ability to suppress non-small-cell lung cancer (NSCLC). Through the induction of apoptosis and the attenuation of epithelial-mesenchymal transition (EMT), the extract demonstrates significant antitumor effects. It further functions by downregulating the PI3K/Akt pathway to inhibit cell migration and invasion. Research using both in vitro cell lines and in vivo mouse models confirms that this petroleum ether extract effectively inhibits tumor growth.